Investor insights
Sectors invested in
Funding rounds participated in
$33M sweet spot round size
Most of their 15 investments are in rounds between $5M and $50M
Investor type
Basic info
Industry
Sectors
Date founded
2010
Investments made
Maze Therapeutics raised $190M on January 10, 2022
Investors: NS Investment, General Catalyst, Casdin Capital, LLC, Foresite Capital, Driehaus Capital Management LLC, Woodline Partners LP and City Hill Ventures
OncoMyx Therapeutics raised $50M on December 9, 2021
Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, Madison Partners, Xeraya Capital, Lumira Ventures, B Capital Group and City Hill Ventures
Undisclosed raised $50M on December 8, 2021
Investors: Delos Capital, Korea Investment Partners, Xeraya Capital, B Capital Group, Lumira Ventures, LYZZ CAPITAL, Madison Partners and City Hill Ventures
Erasca, Inc. raised $200M on April 27, 2020
Investors: EDBI Pte Ltd, LifeSci Venture Partners, ARCH Venture Partners, The Invus Group and City Hill Ventures
Maze Therapeutics raised undisclosed on October 23, 2019
Investors: City Hill Ventures
Boundless Bio raised $46M on September 19, 2019
Investors: ARCH Venture Partners and City Hill Ventures
Undisclosed raised $25M on June 6, 2019
Investors: Korea Investment Partners, Delos Capital, Xeraya Capital, Madison Partners and City Hill Ventures
Erasca, Inc. raised $42M on December 18, 2018
Investors: City Hill Ventures
Undisclosed raised $16M on January 23, 2018
Investors: JMCR Partners, Viva Ventures Biotech Fund and City Hill Ventures
Flex Pharma raised $40M on September 8, 2014
Investors: Correlation Ventures, QVT Financial LLP, Jennison Associates LLC, Spark Capital, Longwood Fund, Lightstone Ventures and City Hill Ventures